关注
Su Phyu
Su Phyu
未知所在单位机构
在 berkeley.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Enhancing CAR-T cell metabolism to overcome hypoxic conditions in the brain tumor microenvironment
R Hatae, K Kyewalabye, A Yamamichi, T Chen, S Phyu, P Chuntova, ...
JCI insight 9 (7), 2024
92024
IL-13Rα2/TGF-β bispecific CAR-T cells counter TGF-β-mediated immune suppression and potentiate anti-tumor responses in glioblastoma
AJ Hou, RM Shih, BR Uy, A Shafer, ZNL Chang, B Comin-Anduix, ...
Neuro-oncology 26 (10), 1850-1866, 2024
72024
A Roadmap of CAR-T-Cell Therapy in Glioblastoma: Challenges and Future Perspectives
M Montoya, M Gallus, S Phyu, J Haegelin, J de Groot, H Okada
Cells 13 (9), 726, 2024
62024
Glioma-neuronal circuit remodeling induces regional immunosuppression
T Nejo, S Krishna, C Jimenez, A Yamamichi, JS Young, ...
bioRxiv, 2023.08. 04.548295, 2023
62023
Tumor Suppressor MicroRNAs in Clinical and Preclinical Trials for Neurological Disorders
A Lui, T Do, O Alzayat, N Yu, S Phyu, HJ Santuya, B Liang, V Kailash, ...
Pharmaceuticals 17 (4), 426, 2024
22024
Low-intensity pulsed ultrasound enhances the presentation of brain-derived antigens by facilitating the migration of antigen-presenting cells from the brain to the periphery
M Gallus, VA Arrieta, A Saijo, P Chuntova, A Yamamichi, J Haegelin, ...
Cancer Research 84 (6_Supplement), 6648-6648, 2024
2024
A Roadmap of CAR-T-Cell Therapy in Glioblastoma: Challenges and Future Perspectives. Cells 2024, 13, 726
M Montoya, M Gallus, S Phyu, J Haegelin, J de Groot, H Okada
2024
EXTH-18. DEVELOPMENT OF A TRANSGENIC MOUSE MODEL ENABLING COMPARATIVE ANALYSIS OF CHIMERIC ANTIGEN RECEPTOR (CAR)-EXPRESSING IMMUNE CELL POPULATIONS FOR CANCER IMMUNOTHERAPY
R Hatae, P Watchmaker, A Yamamichi, K Kyewalabye, K Okada, S Phyu, ...
Neuro-Oncology 25 (Supplement_5), v227-v227, 2023
2023
IMMU-04. LOW-INTENSITY PULSED ULTRASOUND ENHANCES CAR T CELL THERAPY BY INDUCING TWO-WAY IMMUNE CELL TRAFFICKING–T CELL INTO TUMOR AND MYELOID CELL INTO PERIPHERY IN A …
A Yamamichi, T Chen, S Phyu, J Young, K Kyewarabye, R Hatae, ...
Neuro-Oncology 25 (Supplement_5), v141-v142, 2023
2023
843 Intra-cerebral spinal fluid vaccination to facilitate antigen-specific T-cell responses in the CNS tumors
A Yamamichi, S Phyu, T Chen, A Kazuyoshi, N Harada, H Okada
Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023
2023
277 SynNotch-CAR T cells demonstrate potent anti-tumor efficacy in a preclinical immunocompetent mouse model for glioblastoma
S Lakshmanachetty, M Simic, P Watchmaker, A Yamamichi, T Chen, ...
Journal for ImmunoTherapy of Cancer 11 (Suppl 1), 2023
2023
CNSC-06. REDIRECTING IMMUNOSUPPRESSIVE GLIOMA MICROENVIRONMENT THROUGH PHARMACOLOGICAL INTERVENTION TARGETING NEURONAL ACTIVITY
T Nejo, S Krishna, A Yamamichi, C Jimenez, S Lakshmanachetty, ...
Neuro-Oncology 25 (Supplement_5), v23-v23, 2023
2023
Pre-treatment of CAR-T cells with met+ rap improves the mitochondrial function and anti-tumor efficacy in a hypoxic glioma microenvironment
R Hatae, K Kyewalabye, A Yamamichi, T Chen, S Phyu, P Chuntova, ...
Cancer Research 83 (7_Supplement), 1774-1774, 2023
2023
系统目前无法执行此操作,请稍后再试。
文章 1–13